查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771572

美國美容注射市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、細分市場預測，2025-2030 年

U.S. Aesthetic Injectable Market Size, Share & Trends Analysis Report By Product (Hyaluronic Acid, Botulinum Toxin), By Application, By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國美容注射劑市場的趨勢：

預計 2024 年美國美容注射劑市場價值將達到 41 億美元，預計 2025 年至 2030 年的複合年成長率為 11.2%。

隨著消費者期望轉向便利性、個人化和預防保健，美國美容注射產業持續發展。注射劑在廣泛用戶群中的日益普及，以及產品設計的不斷進步，正在改變人們對美容療程的認知和交付方式。 2023年5月，艾爾建美學公司（Allergan Aesthetics）在美國推出了由Juvederm開發的Skinvive，這是一款皮內注射劑，採用基於透明質酸（HA）的微滴，旨在透過增加保濕度和平滑度來改善臉頰皮膚紋理。

非手術美容解決方案的強烈偏好推動了美國美容注射產業的發展。越來越多的消費者選擇注射劑，因為它們方便、恢復時間短，並且能夠帶來自然的效果。這些手術為臉部回春提供了隱藏的選擇，避免了手術帶來的風險和恢復期。快速治療和肉眼可見的改善，非常適合尋求細微改善的專業人士和年輕人的生活方式。根據美國整形外科醫師協會 (ASPS) 2023 年的數據，男性共進行了 147 萬例美容微創手術，其中包括 526,062 次神經調節劑注射和超過 232,000 次填充劑治療。女性共進行了 1,970 萬例美容微創手術，其中包括 820 萬例神經調節劑注射和超過 550 萬例填充劑治療。

注射療法在男性和年輕消費者中越來越受歡迎，他們不僅將注射視為一種矯正措施，更將其視為一種積極主動的自我護理形式。男性通常透過注射來改善臉部特徵，而二、三十歲的人則通常透過注射來防止老化的早期跡象。這種人口結構的變化正在擴大基本客群，並促使提供者根據更多樣化的人群客製化他們的服務和訊息，包括那些尋求保養而非改造的人群。 2024 年 10 月，艾爾建美學公司在佛羅裡達州奧蘭多舉行的 ASDS 年會上展示了新數據，強調了臉部注射劑的安全性和患者滿意度。來自美國各地的患者群體參加了此次報告，並強調了治療效果和社交媒體對患者期望的影響。

持續的技術創新正在塑造注射劑市場的競爭格局。新產品的設計旨在延長使用壽命，與皮膚更加無縫融合，並提供更自然的動態和外觀。這些進步使治療對初次就診和復診患者更具吸引力。差異化配方和針對性應用的發展使品牌能夠更精準、更可靠地解決特定的美學問題。 2025年1月，高德美公司宣布了美國臨床試驗的積極中期結果，該試驗評估了Sculptra聯合治療瑞藍治療藥物性減肥相關的面部體積減少的效果。試驗結果顯示，患者獲得了顯著的美學改善和較高的滿意度。一項為期六個月的延伸研究正在進行中，以評估長期療效。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國美容注射市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國美容注射劑市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國美容注射市場：產品評估與趨勢分析

  • 美國美容注射劑市場：產品儀表板
  • 美國美容注射劑市場：產品趨勢分析
  • 美國美容注射市場（按產品和收益）
  • 透明質酸（HA）
  • 肉毒桿菌素（Botox）
  • 水下光注入
  • 其他

第5章美國美容注射市場：應用評估與趨勢分析

  • 美國美容注射劑市場：應用儀表板
  • 美國美容注射劑市場：應用趨勢分析
  • 美國美容注射劑市場（按應用和收益）
  • 臉部線條矯正
  • 豐唇
  • 拉皮
  • 痤瘡疤痕的治療
  • 脂肪營養障礙的治療
  • 其他

第6章美國美容注射市場：最終用途估算與趨勢分析

  • 美國美容注射劑市場：最終用途儀表板
  • 美國美容注射劑市場：最終用途趨勢分析
  • 美國美容注射劑市場（按最終用途和收益）
  • 醫療水療中心
  • 皮膚科診所
  • 醫院

第7章 競爭態勢

  • 主要製造商的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 主要企業市場佔有率分析（2024年）
  • 公司簡介
    • Ipsen Pharma
    • AbbVie, Inc.
    • Merz GmbH and Co. KGaA
    • Galderma
    • Prollenium Medical Technologies, Inc.
    • Tiger Aesthetics Medical, LLC
    • Sinclair Pharma
    • Medytox, Inc.
    • Revance Therapeutics, Inc.
Product Code: GVR-4-68040-618-8

U.S. Aesthetic Injectable Market Trends:

The U.S. aesthetic injectable market size was estimated at USD 4.1 billion in 2024 and is projected to grow at a CAGR of 11.2% from 2025 to 2030. The U.S. aesthetic injectable industry continues to evolve as consumer expectations shift toward convenience, personalization, and preventative care. The growing popularity of injectables among a broader range of users, along with advances in product design, is changing the way cosmetic treatments are perceived and delivered. In May 2023, Allergan Aesthetics launched Skinvive by Juvederm in the U.S., an intradermal HA-based microdroplet injection designed to improve cheek skin quality by enhancing hydration and smoothness.

A strong preference for non-surgical cosmetic solutions drives the U.S. aesthetic injectable industry. Consumers are increasingly choosing injectables due to their convenience, short recovery time, and ability to deliver natural-looking results. These procedures offer a discreet option for facial rejuvenation without the risks or downtime associated with surgery. The appeal of quick treatments with visible enhancements fits nicely into the lifestyle of professionals and younger individuals seeking subtle improvements. According to the American Society of Plastic Surgeons (ASPS) 2023 data, 1.47 million cosmetic minimally invasive procedures were performed on males, including 526,062 neuromodulator injections and over 232,000 filler treatments. For females, the number reached 19.7 million, with 8.2 million neuromodulator injections and over 5.5 million filler procedures.

Injectable treatments are growing in popularity among men and younger consumers, who view them not just as corrective tools but as a form of proactive self-care. Men are turning to injectables to refine facial features, while individuals in their 20s and 30s often use them to prevent early signs of aging. This shifting demographic has broadened the customer base and encourages providers to tailor services and messaging to a more diverse audience, including those looking for maintenance rather than transformation. In October 2024, Allergan Aesthetics presented new data at the ASDS Annual Meeting in Orlando, Florida, highlighting safety and patient satisfaction with facial injectables. The presentations included diverse patient demographics across the U.S., emphasizing treatment efficacy and social media's impact on patient expectations.

Ongoing innovation is shaping the competitive edge of the injectable market. New products are designed to last longer, integrate more seamlessly with skin, and provide more natural movement and appearance. These advancements make treatments more appealing to first-time users and returning clients. With the development of differentiated formulations and targeted applications, brands can address specific aesthetic concerns with greater precision and reliability. In January 2025, Galderma announced positive interim results from a U.S.-based trial evaluating Sculptra combined with Restylane for treating facial volume loss caused by medication-driven weight loss. The study showed significant aesthetic improvements and high patient satisfaction. A six-month extension is ongoing to assess long-term effects.

U.S. Aesthetic Injectable Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. aesthetic injectable market report based on product, application, and end-use:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Hyaluronic Acid (HA)
  • Botulinum Toxin (Botox)
  • Aquatic Light Injections
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Medical Spas
  • Dermatology Clinics
  • Hospitals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Volume price analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Aesthetic Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for minimally invasive procedures
      • 3.2.1.2. Expanding acceptance among male and younger demographics
      • 3.2.1.3. Continuous product innovation and longer-lasting formulations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Restricted availability and practitioner access in suburban and rural areas
      • 3.2.2.2. Regulatory constraints and lack of insurance coverage
  • 3.3. U.S. Aesthetic Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Aesthetic Injectable Market: Product Estimates & Trend Analysis

  • 4.1. U.S. Aesthetic Injectable Market: Product Dashboard
  • 4.2. U.S. Aesthetic Injectable Market: Product Movement Analysis
  • 4.3. U.S. Aesthetic Injectable Market by Product, Revenue
  • 4.4. Hyaluronic Acid (HA)
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Botulinum Toxin (Botox)
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Aquatic Light Injections
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. Aesthetic Injectable Market: Application Estimates & Trend Analysis

  • 5.1. U.S. Aesthetic Injectable Market: Application Dashboard
  • 5.2. U.S. Aesthetic Injectable Market: Application Movement Analysis
  • 5.3. U.S. Aesthetic Injectable Market by Application, Revenue
  • 5.4. Facial Line Correction
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Lip Augmentation
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Face Lift
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Acne Scar Treatment
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Lipoatrophy Treatment
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Aesthetic Injectable Market: End Use Estimates & Trend Analysis

  • 6.1. U.S. Aesthetic Injectable Market: End Use Dashboard
  • 6.2. U.S. Aesthetic Injectable Market: End Use Movement Analysis
  • 6.3. U.S. Aesthetic Injectable Market by End Use, Revenue
  • 6.4. Medical Spas
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Dermatology Clinics
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
    • 7.2.1. Key company market share analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. Ipsen Pharma
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. AbbVie, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Merz GmbH and Co. KGaA
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Galderma
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Prollenium Medical Technologies, Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Tiger Aesthetics Medical, LLC
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Sinclair Pharma
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Medytox, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Revance Therapeutics, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Participant's overview
  • Table 6 Financial performance
  • Table 7 Key companies undergoing expansions
  • Table 8 Key companies undergoing acquisitions
  • Table 9 Key companies undergoing collaborations
  • Table 10 Key companies launching new services
  • Table 11 Key companies undergoing partnerships
  • Table 12 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. aesthetic injectable market segmentation
  • Fig. 7 Market snapshot, 2024
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 U.S. Aesthetic Injectable Market: Product Outlook Key Takeaways
  • Fig. 14 U.S. Aesthetic Injectable Market: Product Movement Analysis
  • Fig. 15 Hyaluronic acid (HA) market, 2018 - 2030 (USD Million)
  • Fig. 16 Botulinum toxin (Botox) market, 2018 - 2030 (USD Million)
  • Fig. 17 Aquatic light injections market, 2018 - 2030 (USD Million)
  • Fig. 18 Others market, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. aesthetic injectable market: Application outlook key takeaways
  • Fig. 20 U.S. aesthetic injectable market: Application movement analysis
  • Fig. 21 Facial line correction market, 2018 - 2030 (USD Million)
  • Fig. 22 Lip augmentation market, 2018 - 2030 (USD Million)
  • Fig. 23 Face lift market, 2018 - 2030 (USD Million)
  • Fig. 24 Acne scar treatment market, 2018 - 2030 (USD Million)
  • Fig. 25 Lipoatrophy treatment market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. aesthetic injectable market: End use outlook key takeaways
  • Fig. 28 U.S. aesthetic injectable market: End use movement analysis
  • Fig. 29 Medical spas market, 2018 - 2030 (USD Million)
  • Fig. 30 Dermatology clinics market, 2018 - 2030 (USD Million)
  • Fig. 31 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 32 Strategy framework